Inhaled delivery of aerosolized cyclosporine

Advanced Drug Delivery Reviews

Volumn 58, Issue 9-10, 2006, Pages 1119-1127

  Corcoran, T E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Aerosol deposition; Aerosol immunosuppressant; Aerosol pharmacokinetics; Bronchiolitis obliterans; Cyclosporine solution for inhalation; Lung transplant rejection; Lung transplantation

Indexed keywords

IMMUNOLOGY; PATIENT TREATMENT; PHARMACOKINETICS; PULMONARY DISEASES; TRANSPLANTATION (SURGICAL);

AEROSOL DEPOSITION; AEROSOL IMMUNOSUPPRESSANT; AEROSOL PHARMACOKINETICS; BRONCHIOLITIS OBLITERANS; LUNG TRANSPLANT REJECTION; LUNG TRANSPLANTATION;

DRUG PRODUCTS;

CALCINEURIN INHIBITOR; CYCLOSPORIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; PACLITAXEL; PLACEBO;

AEROSOL; BRONCHIOLITIS OBLITERANS; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MULTIVARIATE ANALYSIS; NEBULIZATION; OPEN STUDY; PATHOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; REVIEW; SCINTIGRAPHY; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; TISSUE DISTRIBUTION;

EID: 33751251068     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2006.07.016     Document Type: Review

References (37)

1. The Organ Procurement and Transplantation Network. Lung Transplant Data (2005). http://www.optn.org www.optn.org
2. Moffatt S.D., Demers P., Robbins R.C., Doyle R., Wienacker A., Henig N., Theodore J., Reitz B.A., and Whyte R.I. Lung transplantation: a decade of experience. J. Heart Lung Transplant. 24 (2005) 145-151
3. Kahan B.D. Cyclosporine. N. Engl. J. Med. 321 (1989) 1725-1738
4. Novartis Pharmaceuticals, Drug Label for Sandimmune, East Hanover, NJ.
5. Burkart G.J., Smaldone G.C., Eldon M.A., Venkataramanan R., Dauber J., Zeevi A., McCurry K., McKaveney T.P., Corcoran T.E., Griffith B.P., and Iacono A.T. Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients. Pharm. Res. 20 (2003) 252-256
6. Corcoran T.E., Smaldone G.C., Dauber J.H., Smith D.A., McCurry K.R., Burckart G.J., Zeevi A., Griffith B.P., and Iacono A.T. Preservation of post-transplant lung function with aerosol cyclosporin. Eur. Respir. J. 23 (2004) 378-383
7. Iacono A.T., Corcoran T.E., Griffith B.P., Grgurich W.F., Smith D.A., Zeevi A., Smaldone G.C., McCurry K.R., Johnson B.A., and Dauber J.H. Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur. Respir. J. 23 (2004) 384-390
8. Iacono A.T., Smaldone G.C., Keenan R.J., Diot P., Dauber J.H., Zeevi A., Burckart G.J., and Griffith B.P. Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am. J. Respir. Crit. Care Med. 155 (1997) 1690-1698
9. Keenan R.J., Iacono A., Dauber J.H., Zeevi A., Yousem S.A., Ohori N.P., Burckart G.J., Kawai A., Smaldone G.C., and Griffith B.P. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. J. Thorac. Cardiovasc. Surg. 113 (1997) 335-340 (discussion 340-331)
10. Dowling R.D., Zenati M., Burckart G.J., Yousem S.A., Schaper M., Simmons R.L., Hardesty R.L., and Griffith B.P. Aerosolized cyclosporine as single-agent immunotherapy in canine lung allografts. Surgery 108 (1990) 198-204 (discussion 204-195)
11. Keenan R.J., Duncan A.J., Yousem S.A., Zenati M., Schaper M., Dowling R.D., Alarie Y., Burckart G.J., and Griffith B.P. Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation. Transplantation 53 (1992) 20-25
12. Mitruka S.N., Pham S.M., Zeevi A., Li S., Cai J., Burckart G.J., Yousem S.A., Keenan R.J., and Griffith B.P. Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. J. Thorac. Cardiovasc. Surg. 115 (1998) 28-36 (discussion 36-27)
13. Mitruka S.N., Won A., McCurry K.R., Zeevi A., McKaveney T., Venkataramanan R., Iacono A., Griffith B.P., and Burckart G.J. In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine. J. Heart Lung Transplant. 19 (2000) 969-975
14. Waters V., Sokol S., Reddy B., Soong G., Chun J., and Prince A. The effect of cyclosporine A on airway cell proinflammatory signaling and pneumonia. Am. J. Respir. Cell Mol. Biol. 33 (2005) 138-144
15. Zenati M., Duncan A.J., Burckart G.J., Schaper M., Yousem S.A., Griffith B.P., and Casarotto D. Immunosuppression with aerosolized cyclosporine for prevention of lung rejection in a rat model. Eur. J. Cardio-thorac. Surg. 5 (1991) 266-271 (discussion 272)
16. Letsou G.V., Safi H.J., Reardon M.J., Ergenoglu M., Li Z., Klonaris C.N., Baldwin J.C., Gilbert B.E., and Waldrep J.C. Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression. Ann. Thorac. Surg. 68 (1999) 2044-2048
17. Gilbert B.E., Knight C., Alvarez F.G., Waldrep C., Rodarte J.R., Knight V., and Eschenbacher W.L. Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol. Am. J. Respir. Crit. Care Med. 156 (1997) 1789-1793
18. Koshkina N.V., Golunski E., Roberts L.E., Gilbert B.E., and Knight V. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. J. Aerosol Med. 17 (2004) 7-14
19. A.H. Lefebvre, Atomization and sprays, ed., Hemisphere Pub. Corp., New York 1989.
20. O'Riordan T., Duncan S.R., Burckart G.J., Griffith B.P., and Smaldone G.C. Production of an aerosol of cyclosporine: a prelude to clinical trials. J. Aerosol Med. 5 (1992) 171-177
21. Blot F., Faurisson F., Bernard N., Sellam S., Friard S., Tavakoli R., Carbon C., Stern M., Bisson A., Pocidalo J.J., and Caubarrere I. Nebulized cyclosporine in the rat: assessment of regional lung and extrapulmonary deposition. Transplantation 68 (1999) 191-195
22. Chen Y., Xie Q.M., Shen W.H., and Yang Q.H. Effects of cyclosporin A aerosol on airway hyperresponsiveness in rats. Yao Xue Xue Bao 38 (2003) 492-495
23. Chen Y., Xie Q.M., Yang Q.H., and Chen J.Q. Effect of inhaled cyclosporin A on antigen-induced airway inflammation in asthmatic rats. Yao Xue Xue Bao 39 (2004) 486-490
24. Xie Q.M., Chen J.Q., Shen W.H., Yang Q.H., and Bian R.L. Effects of cyclosporin A by aerosol on airway hyperresponsiveness and inflammation in guinea pigs. Acta Pharmacol. Sin. 23 (2002) 243-247
25. O'Riordan T.G., Iacono A., Keenan R.J., Duncan S.R., Burckart G.J., Griffith B.P., and Smaldone G.C. Delivery and distribution of aerosolized cyclosporine in lung allograft recipients. Am. J. Respir. Crit. Care Med. 151 (1995) 516-521
26. Knoop C., Vervier I., Thiry P., De Backer M., Kovarik J.M., Rousseau A., Marquet P., and Estenne M. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions. Transplantation 76 (2003) 683-688
27. Estenne M., Maurer J.R., Boehler A., Egan J.J., Frost A., Hertz M., Mallory G.B., Snell G.I., and Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J. Heart Lung Transplant. 21 (2002) 297-310
28. Neuringer I.P., Chalermskulrat W., and Aris R. Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review. J. Heart Lung Transplant. 24 (2005) 3-19
29. Kroshus T.J., Kshettry V.R., Savik K., John R., Hertz M.I., and Bolman III R.M. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J. Thorac. Cardiovasc. Surg. 114 (1997) 195-202
30. Iacono A.T., Keenan R.J., Duncan S.R., Smaldone G.C., Dauber J.H., Paradis I.L., Ohori N.P., Grgurich W.F., Burckart G.J., Zeevi A., Delgado E., O'Riordan T.G., Zendarsky M.M., Yousem S.A., and Griffith B.P. Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am. J. Respir. Crit. Care Med. 153 (1996) 1451-1455
31. Eickelberg O., Pansky A., Koehler E., Bihl M., Tamm M., Hildebrand P., Perruchoud A.P., Kashgarian M., and Roth M. Molecular mechanisms of TGF (beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts. FASEB J. 15 (2001) 797-806
32. Johnsson C., Gerdin B., and Tufveson G. Effects of commonly used immunosuppressants on graft-derived fibroblasts. Clin. Exp. Immunol. 136 (2004) 405-412
33. Hostettler K.E., Roth M., Burgess J.K., Johnson P.R., Glanville A.R., Tamm M., Black J.L., and Borger P. Cyclosporine A mediates fibroproliferation through epithelial cells. Transplantation 77 (2004) 1886-1893
34. Citterio F., Pozzetto U., Romagnoli J., Tondolo E., Silvestri P., Nanni G., and Castagneto M. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens. Transplant. Proc. 36 (2004) 698-699
35. Iacono A., Dauber J., Keenan R., Spichty K., Cai J., Grgurich W., Burckart G., Smaldone G., Pham S., Ohori N.P., Yousem S., Williams P., Griffith B., and Zeevi A. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Transplantation 64 (1997) 263-269
36. Iacono A.T., Johnson B.A., Grgurich W.F., Youssef J.G., Corcoran T.E., Seiler D.A., Dauber J.H., Smaldone G.C., Zeevi A., Yousem S.A., Fung J.J., Burckart G.J., and McCurry K.R. A randomized trial of inhaled cyclosporine in lung transplant recipients. N. Engl. J. Med. 354 (2006) 141-150
37. Keenan R.J., Zeevi A., Iacono A.T., Spichty K.J., Cai J.Z., Yousem S.A., Ohori N.P., Paradis I.L., Kawai A., and Griffith B.P. Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics. Surgery 118 (1995) 385-391